Evidence mapPaperPMID 40510064Full record

ArticleCureus2025

Efficacy and Safety of High-Intensity Interval Training in a Patient With Acute Lymphocytic Leukemia Receiving Consolidation Chemotherapy: A Case Report.

Wataru Hanajima, Yuma Hirano, Natsuki Takeda, Tetsuyuki Nagafusa, Katsuya Yamauchi

Abstract readCase Reports
In one paragraph

Article in Cureus, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Wataru HanajimaDepartment of Rehabilitation Medicine, Ayase Heart Rehabilitation Hospital, Tokyo, JPN.
Yuma HiranoDepartment of Rehabilitation Medicine, Hamamatsu University School of Medicine, Shizuoka, JPN.
Natsuki TakedaDepartment of Rehabilitation Medicine, Hamamatsu University School of Medicine, Shizuoka, JPN.
Tetsuyuki NagafusaDepartment of Rehabilitation Medicine, Hamamatsu University School of Medicine, Shizuoka, JPN.
Katsuya YamauchiDepartment of Rehabilitation Medicine, Hamamatsu University School of Medicine, Shizuoka, JPN.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Exercise tolerance prior to hematopoietic stem cell transplantation (HSCT) is an important prognostic indicator. Nevertheless, patients with acute lymphocytic leukemia (ALL) before HSCT have reduced exercise tolerance after multiple rounds of chemotherapy. Exercise is encouraged in these patients to prevent reduced exercise tolerance. However, exercise compliance is reduced during chemotherapy. Therefore, we focused on the potential role of high-intensity interval training (HIIT), which improves exercise tolerance but requires fewer interventions. The efficacy and safety of HIIT in patients undergoing chemotherapy remain unknown. Here, we report an exercise intervention that incorporated HIIT in a patient with ALL undergoing consolidation chemotherapy (CC). The patient was a 40-year-old female diagnosed with ALL for whom rehabilitation was implemented after initiation of induction chemotherapy. The patient underwent aerobic exercise on an ergometer (20 min at 50-60% intensity, using the Karvonen method) and weight-bearing resistance training (three sets of 10-20 repetitions at a 4-5 rating on the modified Borg scale) five times a week. The physical function assessment before the third CC session showed decreased exercise tolerance. An HIIT intervention was added as a more effective rehabilitation strategy for the patient. HIIT was performed on an ergometer. The protocol consisted of a 5-min warm-up, three to four sets of alternating between 80-90% peak oxygen uptake (peak VO

Indexed as

acute lymphoblastic leukemiaconsolidation chemotherapyhematopoietic stem cell transplantationhigh-intensity interval trainingrehabilitation

Identifiers

PMID40510064
PMCPMC12162139

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.